Development, Optimization and Evaluation of 2-Methoxy-Estradiol Loaded Nanocarrier for Prostate Cancer

The therapeutic efficacy of antineoplastic agents possessing a selective target to the nucleus of the cancer cells could be enhanced through novel formulation approaches. Thus, toward the improvement of the anticancer potential of 2-methoxy estradiol (2 ME) on prostate cancer, the drug was entrapped...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Pharmacol
Asıl Yazarlar: Alhakamy, Nabil A., Ahmed, Osama A., Fahmy, Usama A., Asfour, Hani Z., Alghaith, Adel F., Mahdi, Wael A., Alshehri, Sultan, Md, Shadab
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2021
Konular:
Pharmacology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8322574/
https://ncbi.nlm.nih.gov/pubmed/34335251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.682337
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller